Patent · US Active

Method and apparatus for rapid and selective transurethral tissue ablation

US10433906B2 · kind B2 · utility

46Cited by
279References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 17, 2016
Grant dateOct 8, 2019
Priority date
Expiry dateAug 27, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2218/002
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Catheter systems, tools and methods are disclosed for the selective and rapid application of DC voltage pulses to drive irreversible electroporation for minimally invasive transurethral prostate ablation. In one embodiment, a switch unit is used to modulate and apply voltage pulses from a cardiac defibrillator, while in another, the system controller can be configured to apply voltages to an independently selected multiplicity or subsets of electrodes. Devices are disclosed for more effective DC voltage application including the infusion of cooled fluid to elevate the irreversible electroporation threshold of urethral wall tissue and to selectively ablate regions of prostate tissue alone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.